Hotchkis & Wiley Capital Management LLC Has $274.86 Million Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Hotchkis & Wiley Capital Management LLC increased its stake in HCA Healthcare by 29.8%, owning approximately 0.33% of the company after purchasing an additional 182,625 shares.
• HCA Healthcare reported $6.84 earnings per share for the latest quarter, surpassing expectations and showing a 6.4% revenue increase year-over-year.
• The company will pay a quarterly dividend of $0.72 per share on September 30th, representing a dividend yield of 0.7%.

Hotchkis & Wiley Capital Management LLC lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 29.8% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 795,427 shares of the company's stock after purchasing an additional 182,625 shares during the quarter. Hotchkis & Wiley Capital Management LLC owned about 0.33% of HCA Healthcare worth $274,860,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of HCA. Cheviot Value Management LLC acquired a new position in HCA Healthcare during the first quarter worth about $26,000. Atwood & Palmer Inc. acquired a new position in HCA Healthcare during the first quarter worth about $28,000. Bartlett & CO. Wealth Management LLC grew its holdings in HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after acquiring an additional 80 shares during the period. ORG Partners LLC increased its stake in HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after purchasing an additional 86 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. increased its stake in HCA Healthcare by 75.8% in the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after purchasing an additional 50 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Performance

NYSE:HCA traded down $1.05 during mid-day trading on Tuesday, hitting $401.72. 1,180,566 shares of the company's stock traded hands, compared to its average volume of 1,273,427. The firm has a 50 day moving average of $374.60 and a two-hundred day moving average of $354.80. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The firm has a market capitalization of $94.00 billion, a price-to-earnings ratio of 16.40, a price-to-earnings-growth ratio of 1.27 and a beta of 1.39. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 12.11%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on HCA shares. Stephens upgraded HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Morgan Stanley lowered their price objective on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research report on Monday, July 28th. Cantor Fitzgerald reissued an "overweight" rating and set a $444.00 target price on shares of HCA Healthcare in a research note on Tuesday. JPMorgan Chase & Co. increased their price objective on HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. Finally, Robert W. Baird upped their target price on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research report on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $401.83.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.